All In Biotech

Free tool

FAERS Monitor: Toviaz

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 022030 or its brand name (Toviaz, Fesoterodine Fumarate). Reports on generic versions are filed under their own applications.

Reports

10,803

Serious

6,068

56% of reports

Hospitalization

2,327

Death reported

439

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective1,689
  • dry mouth823
  • fall535
  • off label use531
  • fatigue527
  • constipation508
  • urinary retention502
  • pain466
  • headache435
  • dizziness397
  • condition aggravated349
  • confusional state348
  • rash340
  • malaise334
  • nausea327

Reports by year received

View as table
YearReports
20051
20081
200980
20101,035
2011544
2012904
20131,023
2014813
2015618
2016704
2017601
2018677
2019825
2020882
2021619
2022516
2023358
2024265
2025225
2026112

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,043,356 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
urinary retentionSignal50229.727.313,720
dry mouthSignal82319.918.714,694
constipationSignal5084.54.21,412
confusional stateSignal3484.23.8850
fallSignal5353.12.9786
drug ineffectiveSignal1,6892.52.41,614
condition aggravatedSignal3492.22.0241
dizziness3971.61.479
rash3401.51.461
malaise3341.51.353
pain4661.51.473
headache4351.41.241
fatigue5271.31.242
off label use5311.21.115
nausea3270.80.716

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.